Kite Wins EMA Recommendation To Market Tecartus For Leukemia Patients
Executive Summary
The European Medicines Agency has recommended new uses for six approved products, including the CAR T-cell therapy Tecartus.
You may also be interested in...
Rhythm Wins Reimbursement For Obesity Drug Imcivree In France & England
France is set to become the first country in Europe to fund Imcivree for a second – and as yet unapproved – indication. Meanwhile, England has agreed to reimburse the drug for its approved indication as did Germany earlier this year. Reimbursement discussions are underway in the rest of Europe.
EU CHMP Opinions and MAA Updates
This is an update of recommendations from the European Medicines Agency's Committee for Medicinal Products for Human Use on the authorization of new medicines in the European Union, and updates on EU marketing authorization changes recommended by the CHMP.
Janssen’s Multiple Myeloma Drug Among 11 Products To Get EMA Thumbs Up
The European Medicines Agency has cleared the decks for the pan-EU approval of nearly a dozen new drugs. Tecvayli is headed for a conditional approval, while Nulibry is slated to get marketing authorization under exceptional circumstances.